BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32795896)

  • 1. MicroRNA-16 directly binds to DEC2 and inactivates the TLR4 signaling pathway to inhibit lupus nephritis-induced kidney tissue hyperplasia and mesangial cell proliferation.
    Qi H; Cao Q; Liu Q
    Int Immunopharmacol; 2020 Nov; 88():106859. PubMed ID: 32795896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.
    Qi H; Xu L; Liu Q
    Mol Med; 2023 Jul; 29(1):99. PubMed ID: 37488524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis.
    Sheng ZX; Yao H; Cai ZY
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1737-1743. PubMed ID: 29630120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
    Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
    Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
    Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
    Front Immunol; 2021; 12():747616. PubMed ID: 34745118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa‑miR‑371‑5p inhibits human mesangial cell proliferation and promotes apoptosis in lupus nephritis by directly targeting hypoxia‑inducible factor 1α.
    Yao F; Sun L; Fang W; Wang H; Yao D; Cui R; Xu J; Wang L; Wang X
    Mol Med Rep; 2016 Dec; 14(6):5693-5698. PubMed ID: 27878241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells.
    Han X; Wang Y; Zhang X; Qin Y; Qu B; Wu L; Ma J; Zhou Z; Qian J; Dai M; Tang Y; Chan EK; Harley JB; Zhou S; Shen N
    Arthritis Rheumatol; 2016 Sep; 68(9):2232-43. PubMed ID: 27111096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1.
    Qi H; Cao Q; Liu Q
    Exp Cell Res; 2020 Sep; 394(2):112138. PubMed ID: 32535034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis.
    Liu D; Zhang N; Zhang J; Zhao H; Wang X
    Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):616-25. PubMed ID: 27028192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis.
    Qingjuan L; Xiaojuan F; Wei Z; Chao W; Pengpeng K; Hongbo L; Sanbing Z; Jun H; Min Y; Shuxia L
    Am J Physiol Cell Physiol; 2016 Mar; 310(6):C470-8. PubMed ID: 26791485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NEAT1 accelerates renal mesangial cell injury via modulating the miR-146b/TRAF6/NF-κB axis in lupus nephritis.
    Zhang LH; Xiao B; Zhong M; Li Q; Chen JY; Huang JR; Rao H
    Cell Tissue Res; 2020 Dec; 382(3):627-638. PubMed ID: 32710276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis.
    Kong J; Li L; Lu Z; Song J; Yan J; Yang J; Gu Z; Da Z
    Inflammation; 2019 Feb; 42(1):255-263. PubMed ID: 30209639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA Gm6135 functions as a competitive endogenous RNA to regulate toll-like receptor 4 expression by sponging miR-203-3p in diabetic nephropathy.
    Ji TT; Wang YK; Zhu YC; Gao CP; Li XY; Li J; Bai F; Bai SJ
    J Cell Physiol; 2019 May; 234(5):6633-6641. PubMed ID: 30295314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated microRNA-485 suppresses apoptosis of renal tubular epithelial cells in mice with lupus nephritis via regulating the TGF-β-MAPK signaling pathway by inhibiting RhoA expression.
    Tian Y; Han YX; Guo HF; Jin HT; Sun C; Qi X; Ma LY; Bo SW
    J Cell Biochem; 2018 Nov; 119(11):9154-9167. PubMed ID: 30145800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis.
    Shui HA; Ka SM; Wu WM; Lin YF; Hou YC; Su LC; Chen A
    Rheumatology (Oxford); 2007 Aug; 46(8):1277-84. PubMed ID: 17569745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of lupus nephritis is regulated by USP7-mediated JMJD3 stabilization.
    Zhang F; Zhang B; Tang R; Jiang H; Ji Z; Chen Y; Feng H
    Immunol Lett; 2021 Jul; 235():41-50. PubMed ID: 33895173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis.
    Costa-Reis P; Russo PA; Zhang Z; Colonna L; Maurer K; Gallucci S; Schulz SW; Kiani AN; Petri M; Sullivan KE
    Arthritis Rheumatol; 2015 Sep; 67(9):2415-26. PubMed ID: 26016809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling.
    Xu ZQ; Ding Y; Huang XY; Xiang W; He XJ
    Inflammation; 2021 Oct; 44(5):2106-2119. PubMed ID: 34091806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-130a protects against lipopolysaccharide-induced glomerular cell injury by upregulation of Klotho.
    Liang H; Yang K; Xin M; Liu X; Zhao L; Liu B; Wang J
    Pharmazie; 2017 Aug; 72(8):468-474. PubMed ID: 29441906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.
    Diao L; Tao J; Wang Y; Hu Y; He W
    Int J Nanomedicine; 2019; 14():8627-8645. PubMed ID: 31806961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.